Vitamin D and Cardiovascular Disease: An Updated Narrative Review
暂无分享,去创建一个
[1] J. Manson,et al. Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial. , 2020, JAMA.
[2] R. Erben,et al. Vitamin D and Cardiovascular Disease, with Emphasis on Hypertension, Atherosclerosis, and Heart Failure , 2020, International journal of molecular sciences.
[3] A. Saba,et al. An Update on Vitamin D Metabolism , 2020, International journal of molecular sciences.
[4] S. Pilz,et al. The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials , 2020, European Journal of Clinical Nutrition.
[5] R. Jorde,et al. Vitamin D Supplementation for Prevention of Type 2 Diabetes Mellitus: To D or Not to D? , 2020, The Journal of clinical endocrinology and metabolism.
[6] M. Holick,et al. Immunologic Effects of Vitamin D on Human Health and Disease , 2020, Nutrients.
[7] J. Linseisen,et al. Role of Vitamin D in Preventing and Treating Selected Extraskeletal Diseases—An Umbrella Review , 2020, Nutrients.
[8] Dongdong Zhang,et al. Effect of Vitamin D on Blood Pressure and Hypertension in the General Population: An Update Meta-Analysis of Cohort Studies and Randomized Controlled Trials , 2020, Preventing chronic disease.
[9] Chih-Yang Hsu,et al. The effects of correction of vitamin D deficiency on arterial stiffness: A systematic review and updated meta-analysis of randomized controlled trials , 2019, The Journal of Steroid Biochemistry and Molecular Biology.
[10] M. Holick. Sunlight, UV Radiation, Vitamin D, and Skin Cancer: How Much Sunlight Do We Need? , 2020, Advances in experimental medicine and biology.
[11] D. Dibaba,et al. Effect of vitamin D supplementation on serum lipid profiles: a systematic review and meta-analysis. , 2019, Nutrition reviews.
[12] J. Manson,et al. Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial. , 2019, JAMA.
[13] G. Moradi,et al. The association between circulating 25-hydroxyvitamin D and cardiovascular diseases: a meta-analysis of prospective cohort studies , 2019, BMC Cardiovascular Disorders.
[14] H-L Yi,et al. The association between vitamin D receptor gene polymorphism and susceptibility to hypertension: a meta-analysis. , 2019, European review for medical and pharmacological sciences.
[15] N. Smart,et al. Effect of vitamin D supplementation on endothelial function - An updated systematic review with meta-analysis and meta-regression. , 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[16] R. Bouillon,et al. Vitamin D and cardiovascular disorders , 2019, Osteoporosis International.
[17] S. Vettoretti,et al. Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice , 2019, Nutrients.
[18] Juan Ou-Yang,et al. Low serum vitamin D levels increase the mortality of cardiovascular disease in older adults , 2019, Medicine.
[19] Shi-kun Yang,et al. The Impact of Vitamin D Receptor Gene Polymorphisms on the Susceptibility of Diabetic Vascular Complications: A Meta-Analysis. , 2019, Genetic testing and molecular biomarkers.
[20] J. Manson,et al. Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis. , 2019, JAMA cardiology.
[21] J. Ware,et al. Vitamin D Supplementation and Prevention of Type 2 Diabetes. , 2019, The New England journal of medicine.
[22] Marc A Pfeffer,et al. Heart Failure With Preserved Ejection Fraction In Perspective. , 2019, Circulation research.
[23] Zhiqian Min,et al. Meta-analysis of vitamin D supplementation in the treatment of chronic heart failure , 2019, Scandinavian cardiovascular journal : SCJ.
[24] J. Gummert,et al. Vitamin D supplementation of 4000 IU daily and cardiac function in patients with advanced heart failure: The EVITA trial. , 2019, International journal of cardiology.
[25] M. Petkovich,et al. Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease , 2019, American Journal of Nephrology.
[26] Naijing Ye,et al. Vitamin D supplementation for the improvement of vascular function in patients with chronic kidney disease: a meta-analysis of randomized controlled trials , 2019, International Urology and Nephrology.
[27] A. Slominski,et al. The serum vitamin D metabolome: What we know and what is still to discover , 2019, The Journal of Steroid Biochemistry and Molecular Biology.
[28] W. März,et al. Vitamin D testing and treatment: a narrative review of current evidence , 2019, Endocrine connections.
[29] J. Manson,et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease , 2019, The New England journal of medicine.
[30] K. Cashman,et al. Is vitamin D deficiency a public health concern for low middle income countries? A systematic literature review , 2019, European Journal of Nutrition.
[31] N. Yorioka,et al. Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial , 2018, JAMA.
[32] David W. Johnson,et al. Vitamin D status and mortality risk among patients on dialysis: a systematic review and meta-analysis of observational studies , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] P. Dong,et al. Effect of vitamin D on ventricular remodelling in heart failure: a meta-analysis of randomised controlled trials , 2018, BMJ Open.
[34] M. Adorni,et al. Vitamin D replacement ameliorates serum lipoprotein functions, adipokine profile and subclinical atherosclerosis in pre-menopausal women. , 2018, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[35] M. Hiligsmann,et al. Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper , 2018, Front. Endocrinol..
[36] N. Mirhosseini,et al. Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis , 2018, Front. Cardiovasc. Med..
[37] G. Davey Smith,et al. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians , 2018, British Medical Journal.
[38] E. Giovannucci,et al. Supplemental Vitamins and Minerals for CVD Prevention and Treatment. , 2018, Journal of the American College of Cardiology.
[39] Ryan A. Harris,et al. Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta‐Analysis , 2018, Journal of the American Heart Association.
[40] R. Jorde,et al. Serum cholecalciferol may be a better marker of vitamin D status than 25-hydroxyvitamin D. , 2018, Medical hypotheses.
[41] P. Lips,et al. Global Overview of Vitamin D Status. , 2017, Endocrinology and metabolism clinics of North America.
[42] Yufei Shi,et al. Genetic Causes of Rickets , 2017, Journal of clinical research in pediatric endocrinology.
[43] R. Jorde,et al. Vitamin D Stored in Fat Tissue During a 5-Year Intervention Affects Serum 25-Hydroxyvitamin D Levels the Following Year , 2017, The Journal of clinical endocrinology and metabolism.
[44] J. Gummert,et al. Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily , 2017, European heart journal.
[45] V. Gudnason,et al. Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data , 2017, PloS one.
[46] Kay-Tee Khaw,et al. Effect of Monthly High-Dose Vitamin D Supplementation on Cardiovascular Disease in the Vitamin D Assessment Study: A Randomized Clinical Trial , 2017, JAMA cardiology.
[47] G. Wang,et al. Effects of vitamin D or its analogues on the mortality of patients with chronic kidney disease: an updated systematic review and meta-analysis , 2017, European Journal of Clinical Nutrition.
[48] Yilong Wang,et al. Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies. , 2017, The American journal of clinical nutrition.
[49] Shouling Wu,et al. Vitamin D and hypertension: Prospective study and meta-analysis , 2017, PloS one.
[50] K. Djafarian,et al. Common Variants of Vitamin D Receptor Gene Polymorphisms and Susceptibility to Coronary Artery Disease: A Systematic Review and Meta-Analysis , 2017, Lifestyle Genomics.
[51] A. Zittermann,et al. Calciotropic and phosphaturic hormones in heart failure. , 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[52] J. Brent Richards,et al. Mendelian Randomization Studies Do Not Support a Role for Vitamin D in Coronary Artery Disease , 2016, Circulation. Cardiovascular genetics.
[53] W. März,et al. Vitamin D and cardiovascular disease prevention , 2016, Nature Reviews Cardiology.
[54] Fen Hu,et al. The Associations Between the Polymorphisms of Vitamin D Receptor and Coronary Artery Disease , 2016, Medicine.
[55] V. Srikanth,et al. Effect of vitamin D supplementation on measures of arterial stiffness: a systematic review and meta‐analysis of randomized controlled trials , 2016, Clinical endocrinology.
[56] Wei-Long Jiang,et al. Vitamin D Supplementation in the Treatment of Chronic Heart Failure: A Meta‐analysis of Randomized Controlled Trials , 2016, Clinical cardiology.
[57] L. Liao,et al. Association of chemokine ligand 5/chemokine receptor 5 gene promoter polymorphisms with diabetic microvascular complications: A meta‐analysis , 2015, Journal of diabetes investigation.
[58] C. Mølgaard,et al. Vitamin D deficiency in Europe: pandemic? , 2016 .
[59] M. Stojanović,et al. Vitamin D versus placebo in improvement of endothelial dysfunction: a meta-analysis of randomized clinical trials. , 2015, Cardiovascular therapeutics.
[60] R. Jorde,et al. Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data. , 2015, JAMA internal medicine.
[61] Shoaib Afzal,et al. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study. , 2015, International journal of epidemiology.
[62] S. Bojesen,et al. Genetically low vitamin D concentrations and increased mortality: mendelian randomisation analysis in three large cohorts , 2014, BMJ : British Medical Journal.
[63] C. Greenwood,et al. The Causal Effect of Vitamin D Binding Protein (DBP) Levels on Calcemic and Cardiometabolic Diseases: A Mendelian Randomization Study , 2014, PLoS medicine.
[64] A. Folsom,et al. Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study. , 2014, The American journal of clinical nutrition.
[65] Xuefeng Yu,et al. Associations study of vitamin D receptor gene polymorphisms with diabetic microvascular complications: a meta-analysis. , 2014, Gene.
[66] Ross M. Fraser,et al. Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study , 2014, The lancet. Diabetes & endocrinology.
[67] W. Rathmann,et al. Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States , 2014, BMJ : British Medical Journal.
[68] F. Hirche,et al. Dietary vitamin D inadequacy accelerates calcification and osteoblast-like cell formation in the vascular system of LDL receptor knockout and wild-type mice. , 2014, The Journal of nutrition.
[69] M. Wolf,et al. Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease , 2014, Nature Reviews Nephrology.
[70] I. Reid,et al. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. , 2014, The lancet. Diabetes & endocrinology.
[71] O. Franco,et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies , 2014, BMJ : British Medical Journal.
[72] J. Powell,et al. Vitamin D and cardiovascular disease. , 2014, Circulation research.
[73] P. Autier,et al. Vitamin D status and ill health: a systematic review. , 2014, The lancet. Diabetes & endocrinology.
[74] Efsa Panel on Dietetic Products. Scientific Opinion on Dietary Reference Values for vitamin A , 2015 .
[75] H. Armbrecht,et al. FGF-23 Regulates CYP27B1 Transcription in the Kidney and in Extra-Renal Tissues , 2013, PloS one.
[76] B. Nordestgaard,et al. 25‐Hydroxyvitamin D and symptomatic ischemic stroke: An Original Study and Meta‐Analysis , 2013, Annals of neurology.
[77] Khalid M. Alharbi,et al. Hypocalcemic rachitic cardiomyopathy in infants. , 2013, Journal of the Saudi Heart Association.
[78] J. Bacchetta,et al. Beyond mineral metabolism, is there an interplay between FGF23 and vitamin D in innate immunity? , 2013, Pediatric Nephrology.
[79] D. Viswanath,et al. Dietary Reference Intakes for Calcium and Vitamin D , 2012, Pediatrics.
[80] J. Manson,et al. Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies , 2012, Circulation. Cardiovascular quality and outcomes.
[81] F. Hirche,et al. Vitamin D Receptor Deficiency and Low Vitamin D Diet Stimulate Aortic Calcification and Osteogenic Key Factor Expression in Mice , 2012, PloS one.
[82] S. Shedeed. Vitamin D Supplementation in Infants With Chronic Congestive Heart Failure , 2012, Pediatric Cardiology.
[84] Christopher S. Law,et al. Cardiomyocyte-Specific Deletion of the Vitamin D Receptor Gene Results in Cardiac Hypertrophy , 2011, Circulation.
[85] V. Montori,et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. , 2011, The Journal of clinical endocrinology and metabolism.
[86] Daniel L. Koller,et al. Association of the Vitamin D Metabolism Gene CYP24A1 With Coronary Artery Calcification , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[87] R. Koerfer,et al. Protective and toxic effects of vitamin D on vascular calcification: clinical implications. , 2008, Molecular aspects of medicine.
[88] Christopher S. Law,et al. Expression of the Vitamin D Receptor Is Increased in the Hypertrophic Heart , 2008, Hypertension.
[89] K. Cao,et al. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. , 2008, Kidney international.
[90] M. Holick. Sunlight, UV-radiation, vitamin D and skin cancer: how much sunlight do we need? , 2008, Advances in experimental medicine and biology.
[91] K. Nanjo,et al. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23. , 2008, Internal medicine.
[92] Y. Zorbas,et al. Phosphate homeotasis in healthy subjects during prolonged periodic and continuous hypokinesia. , 2007, Clinical biochemistry.
[93] Mikael Fogelholm,et al. [Nordic nutrition recommendations]. , 2006, Ugeskrift for laeger.
[94] N. Stern,et al. 25-Hydroxyvitamin D3-1α-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds , 2005, Circulation.
[95] Guilin Qiao,et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. , 2005, American journal of physiology. Endocrinology and metabolism.
[96] S. Jan de Beur. Tumor-induced osteomalacia. , 2005, JAMA.
[97] Yoko Yamamoto,et al. Disruption of Nuclear Vitamin D Receptor Gene Causes Enhanced Thrombogenicity in Mice* , 2004, Journal of Biological Chemistry.
[98] Kozo Nakamura,et al. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. , 2004, The Journal of clinical endocrinology and metabolism.
[99] Guilin Qiao,et al. Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure , 2004, The Journal of Steroid Biochemistry and Molecular Biology.
[100] G. Tenderich,et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? , 2003, Journal of the American College of Cardiology.
[101] Shu Q. Liu,et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. , 2002, The Journal of clinical investigation.
[102] M. Välimäki,et al. Does it make a difference how and when you take your calcium? The acute effects of calcium on calcium and bone metabolism. , 2001, The American journal of clinical nutrition.
[103] R. Foley,et al. Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[104] P. Avery,et al. Cardiac failure secondary to hypocalcaemia of nutritional osteomalacia. , 1992, European heart journal.
[105] G. Jahreis,et al. [Vitamin D-induced tissue calcinosis and arteriosclerosis changes. I: A contribution to the 60 year history of vitamin D research with special reference to childhood]. , 1990, Padiatrie und Grenzgebiete.
[106] F. Singer,et al. Pharmacokinetics and biologic effects of calcitriol in normal humans. , 1985, The Journal of laboratory and clinical medicine.
[107] R. Francis,et al. Plasma total and ionised calcium, albumin and globulin concentrations in pre- and post-menopausal women and the effects of oestrogen administration. , 1982, Clinica chimica acta; international journal of clinical chemistry.
[108] E. Mawer,et al. The distribution and storage of vitamin D and its metabolites in human tissues. , 1972, Clinical science.